Related Experiment Videos
Of orphans and balloons.
1Aetna Health Plans, Hartford, CT.
Physician Executive
|August 7, 1991
Summary
New healthcare technologies, including orphan drugs and BPH treatments, significantly increase costs. Careful evaluation and monitoring of their utilization are crucial for managing healthcare expenditures and controlling financial drains on payers.
Area of Science:
- Health economics
- Medical technology assessment
- Healthcare policy
Background:
- Healthcare systems face increasing financial burdens from novel technologies.
- These technologies encompass a wide range, from orphan drugs for rare diseases to devices for common conditions like benign prostatic hyperplasia (BPH).
- The rising cost of medical innovations necessitates careful financial management.
Purpose of the Study:
- To highlight the financial implications of new technologies in healthcare.
- To emphasize the need for evaluating and controlling the utilization of these technologies.
- To address the impact on third-party payers.
Main Methods:
- The abstract does not specify methods, but implies a review or analysis of healthcare expenditure trends.
- Focus is on the economic impact of technology adoption.
- Discussion centers on the necessity of utilization management.
Main Results:
- Technologies, such as orphan drugs and BPH treatments, represent significant expenditures.
- These costs pose a potential financial drain on third-party payers.
- Effective utilization management is identified as a key strategy.
Conclusions:
- Careful evaluation, monitoring, and control of technology utilization are essential.
- Managing the financial impact of new healthcare technologies is critical for sustainability.
- Proactive financial stewardship is required to mitigate expenditure increases.